Northeast Financial Consultants’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $271K | Hold |
4,140
| – | – | 0.01% | 263 |
|
|
2025
Q1 | $292K | Hold |
4,140
| – | – | 0.01% | 243 |
|
|
2024
Q4 | $272K | Hold |
4,140
| – | – | 0.01% | 249 |
|
|
2024
Q3 | $292K | Hold |
4,140
| – | – | 0.01% | 238 |
|
|
2024
Q2 | $275K | Hold |
4,140
| – | – | 0.01% | 235 |
|
|
2024
Q1 | $281K | Hold |
4,140
| – | – | 0.01% | 243 |
|
|
2023
Q4 | $256K | Hold |
4,140
| – | – | 0.01% | 240 |
|
|
2023
Q3 | $244K | Hold |
4,140
| – | – | 0.02% | 243 |
|
|
2023
Q2 | $247K | Hold |
4,140
| – | – | 0.02% | 245 |
|
|
2023
Q1 | $242K | Hold |
4,140
| – | – | 0.02% | 272 |
|
|
2022
Q4 | $257K | Hold |
4,140
| – | – | 0.02% | 260 |
|
|
2022
Q3 | $234K | Hold |
4,140
| – | – | 0.02% | 292 |
|
|
2022
Q2 | $264K | Hold |
4,140
| – | – | 0.02% | 272 |
|
|
2022
Q1 | $268K | Hold |
4,140
| – | – | 0.02% | 322 |
|
|
2021
Q4 | $275K | Hold |
4,140
| – | – | 0.02% | 294 |
|
|
2021
Q3 | $253K | Hold |
4,140
| – | – | 0.02% | 302 |
|
|
2021
Q2 | $256K | Hold |
4,140
| – | – | 0.02% | 304 |
|
|
2021
Q1 | $245K | Hold |
4,140
| – | – | 0.02% | 299 |
|
|
2020
Q4 | $248K | Hold |
4,140
| – | – | 0.02% | 281 |
|
|
2020
Q3 | $226K | Hold |
4,140
| – | – | 0.02% | 266 |
|
|
2020
Q2 | $212K | Buy |
+4,140
| New | +$212K | 0.02% | 262 |
|
|
2020
Q1 | – | Sell |
-4,140
| Closed | -$221K | – | 288 |
|
|
2019
Q4 | $221K | Buy |
+4,140
| New | +$221K | 0.02% | 274 |
|
|
2019
Q3 | – | Sell |
-4,140
| Closed | -$208K | – | 325 |
|
|
2019
Q2 | $208K | Hold |
4,140
| – | – | 0.02% | 303 |
|
|
2019
Q1 | $212K | Buy |
+4,140
| New | +$212K | 0.02% | 290 |
|
|
2018
Q4 | – | Sell |
-4,140
| Closed | -$231K | – | 177 |
|
|
2018
Q3 | $231K | Buy |
+4,140
| New | +$231K | 0.06% | 132 |
|